{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:15:06Z","timestamp":1777349706122,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Austrian Ministry of Health"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.vaccine.2011.05.046","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T18:28:27Z","timestamp":1307557707000},"page":"5130-5136","source":"Crossref","is-referenced-by-count":15,"title":["Persistence of antibodies in 4\u20138 year old Austrian children after vaccination with hexavalent DTaP\u2013HBV\u2013IPV\/Hib and MMR vaccines"],"prefix":"10.1016","volume":"29","author":[{"given":"Maria","family":"Paulke-Korinek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustav","family":"Fischmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Grac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Rendi-Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsaneh","family":"Mohsenzadeh-Rabbani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Fenninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhart","family":"Jarisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Jasinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidemarie","family":"Holzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula","family":"Wiedermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herwig","family":"Kollaritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.05.046_bib0005","unstructured":"\u00d6sterreichische Apotheker-Verlagsges.m.b.H. Impfplan; 2003. Available at: http:\/\/www.oeaz.at\/zeitung\/3aktuell\/2003\/05\/haupt\/haupt05_2003empf.html [accessed 12.10.2009]."},{"key":"10.1016\/j.vaccine.2011.05.046_bib0010","unstructured":"DadeBehring. Enzygnost\u00ae Anti-Masern-Virus\/IgG; 2003. Available at: http:\/\/www.tecnopoint-rj.com.br\/downloads\/virologia\/Enzygnost_Anti-Masern-Virus-IgG-ingl.pdf [accessed 21.07.2009]."},{"key":"10.1016\/j.vaccine.2011.05.046_bib0015","unstructured":"Lennette EH, Schmidt NJ. Haemaggutination inhibition (HAI). In: Lennette EH, Schmidt NJ, editors. Diagnostic procedures for viral, rickettsial and chlamydial infections; 1979. p. 744\u201351."},{"key":"10.1016\/j.vaccine.2011.05.046_bib0020","series-title":"Rubella vaccine","first-page":"735","author":"Plotkin","year":"2008"},{"key":"10.1016\/j.vaccine.2011.05.046_bib0025","unstructured":"Galazka A. The immunological basis for immunisation series. Module 2: diphtheria. In: World Health Organization, editor. Global programme for vaccines and immunization, expanded programme on immunisation Switzerland; 1993."},{"key":"10.1016\/j.vaccine.2011.05.046_bib0030","unstructured":"Galazka A. The immunological basis for immunisation series. Module 3: tetanus. In: World Health Organization, editor. Global programme for vaccines and immunization, expanded programme on immunisation Switzerland; 1993."},{"key":"10.1016\/j.vaccine.2011.05.046_bib0035","unstructured":"Savyon\u00ae Diagnostics. SeroPertussis IgG; 2007. Available at: http:\/\/gsdx.org\/images\/productspdf\/A231-01.pdf [accessed 12.10.2009]."},{"key":"10.1016\/j.vaccine.2011.05.046_bib0040","unstructured":"Oberster Sanit\u00e4tsrat. Impfplan 2009 \u00d6sterreich; 2008. Available at: http:\/\/www.bmgfj.gv.at\/cms\/site\/attachments\/1\/4\/0\/CH0780\/CMS1038913010412\/impfplan_2009_final.pdf [accessed 21.01.2010]."},{"key":"10.1016\/j.vaccine.2011.05.046_bib0045","series-title":"Measles vaccine","first-page":"353","author":"Strebel","year":"2008"},{"key":"10.1016\/j.vaccine.2011.05.046_bib0050","first-page":"CD004407","article-title":"Vaccines for measles, mumps and rubella in children","volume":"4","author":"Demicheli","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.046_bib0055","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1023038705835","article-title":"Fully vaccinated children are rare: immunization coverage and seroprevalence in Austrian school children","volume":"18","author":"Ringler","year":"2003","journal-title":"Eur J Epidemiol"},{"issue":"14","key":"10.1016\/j.vaccine.2011.05.046_bib0060","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1016\/j.vaccine.2005.12.015","article-title":"Waning antibodies in measles and rubella vaccines \u2013 a longitudinal study","volume":"24","author":"Kremer","year":"2006","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.046_bib0065","first-page":"415","article-title":"Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China","volume":"69","author":"Dai","year":"1991","journal-title":"Bull World Health Org"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.046_bib0070","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.05.046_bib0075","unstructured":"EUROIMMUN, Medizinische Labordiagnostika AG. Anti-Mumpvirus-ELISA (IgG); 2001. Available at: http:\/\/www.euroimmun.ch\/uploads\/media\/EI_2630_D_DE_A01_02.pdf [accessed 20.07.2009]."},{"key":"10.1016\/j.vaccine.2011.05.046_bib0080","series-title":"Mumps vaccine","first-page":"435","author":"Plotkin","year":"2008"},{"issue":"15","key":"10.1016\/j.vaccine.2011.05.046_bib0085","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.vaccine.2009.02.001","article-title":"Effectiveness of Jeryl Lynn-containing vaccine in Spanish children","volume":"27","author":"Castilla","year":"2009","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2011.05.046_bib0090","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1016\/j.vaccine.2005.05.018","article-title":"Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G","volume":"23","author":"Sanz-Moreno","year":"2005","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2011.05.046_bib0095","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1086\/521029","article-title":"Cellular immunity to mumps virus in young adults 21 years after measles\u2013mumps\u2013rubella vaccination","volume":"196","author":"Jokinen","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.05.046_bib0100","first-page":"559","article-title":"Update: multistate outbreak of mumps \u2013 United States, January 1\u2013May 2, 2006","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR"},{"issue":"24","key":"10.1016\/j.vaccine.2011.05.046_bib0105","article-title":"Mumps outbreak affecting adolescents and young adults in Austria","volume":"11","author":"Schmid","year":"2006","journal-title":"Euro Surveill"},{"issue":"4","key":"10.1016\/j.vaccine.2011.05.046_bib0110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4049\/jimmunol.99.4.785","article-title":"The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status","volume":"99","author":"Lennette","year":"1967","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.05.046_bib0115","unstructured":"Skendzel LP, Kiefer DJ, Nakamura RM, Nutter CD, Schaefer LE, Stewart JA. Detection and quantitation of rubella IgG Antibody: evaluation and performance criteria for multiple component test products, specimen handling, and use of test products in the clinical laboratory; approved guideline. Providin NCCLS standards and guidelines 1997;17(17)."},{"issue":"6","key":"10.1016\/j.vaccine.2011.05.046_bib0120","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1086\/605410","article-title":"Persistence of rubella antibodies after 2 doses of measles\u2013mumps\u2013rubella vaccine","volume":"200","author":"LeBaron","year":"2009","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2011.05.046_bib0125","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.05.046_bib0130","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00006454-199503000-00007","article-title":"Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal","volume":"14","author":"Samb","year":"1995","journal-title":"Pediatr Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2011.05.046_bib0135","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1086\/588195","article-title":"Immune responses to mumps vaccine in adults who were vaccinated in childhood","volume":"197","author":"Hanna-Wakim","year":"2008","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2011.05.046_bib0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/vim.2009.0068","article-title":"Correlation between rubella antibody levels and cytokine measures of cell-mediated immunity","volume":"22","author":"Tosh","year":"2009","journal-title":"Viral Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.05.046_bib0145","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00431-006-0403-x","article-title":"Booster vaccination and 1-year follow-up of 4\u20138-year-old children with a reduced-antigen-content dTpa\u2013IPV vaccine","volume":"166","author":"S\u00e4nger","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"8","key":"10.1016\/j.vaccine.2011.05.046_bib0150","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1023\/A:1025375932257","article-title":"Immune response to a diphtheria and tetanus toxoid administration in a three-dose diphtheria tetanus whole-cell pertussis\/enhanced inactivated poliovirus vaccination schedule: a 7-year follow up","volume":"18","author":"Swartz","year":"2003","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.05.046_bib0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00431-005-1763-3","article-title":"Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose","volume":"165","author":"Trollfors","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2011.05.046_bib0160","unstructured":"EUVAC.NET. A surveillance community network for vaccine preventable infectious diseases; 2010. Available at: http:\/\/www.euvac.net\/graphics\/euvac\/vaccination\/vaccination.html [accessed 23.03.2010]."},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.046_bib0165","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0264-410X(87)90057-0","article-title":"Evaluation of vaccination requirements to secure continuous antitoxin immunity to tetanus","volume":"5","author":"Simonsen","year":"1987","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2011.05.046_bib0170","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.vaccine.2005.02.013","article-title":"Combined reduced-antigen-content diphtheria\u2013tetanus\u2013acellular pertussis and polio vaccine (dTpa\u2013IPV) for booster vaccination of adults","volume":"23","author":"Grimprel","year":"2005","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2011.05.046_bib0175","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/INF.0b013e318124a9dd","article-title":"Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria","volume":"26","author":"Rendi-Wagner","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2011.05.046_bib0180","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1086\/514338","article-title":"Immunity to pertussis 5 years after booster immunization during adolescence","volume":"44","author":"Edelman","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"52","key":"10.1016\/j.vaccine.2011.05.046_bib0185","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1016\/j.vaccine.2008.09.064","article-title":"Differences of humoral and cellular immune response to an acellular pertussis booster in adolescents with a whole cell or acellular primary vaccination","volume":"26","author":"Rieber","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2011.05.046_bib0190","series-title":"Vaccines","first-page":"205","article-title":"Hepatitis B vaccines","author":"Mast","year":"2008"},{"key":"10.1016\/j.vaccine.2011.05.046_bib0195","unstructured":"European Medicines Agency. European Medicines Agency recommends suspension of Hexavac; 2005. Available at: http:\/\/www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/Hexavac\/29736905en.pdf [accessed 23.03.2010]."},{"issue":"8","key":"10.1016\/j.vaccine.2011.05.046_bib0200","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2334-8-100","article-title":"A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines","volume":"28","author":"Giambi","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.05.046_bib0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tmaid.2006.04.004","article-title":"A review of the long-term protection after hepatitis A and B vaccination","volume":"5","author":"Van Damme","year":"2007","journal-title":"Travel Med Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2011.05.046_bib0210","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0264-410X(96)00062-X","article-title":"Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination","volume":"14","author":"West","year":"1996","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.05.046_bib0215","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/INF.0b013e31817702ba","article-title":"Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study","volume":"27","author":"Bialek","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"39\u201340","key":"10.1016\/j.vaccine.2011.05.046_bib0220","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1016\/j.vaccine.2007.06.059","article-title":"Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years","volume":"25","author":"Hammitt","year":"2007","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2011.05.046_bib0225","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1016\/j.vaccine.2007.09.013","article-title":"Hepatitis B seroprevalence and anamnestic response amongst Taiwanese young adults with full vaccination in infancy, 20 years subsequent to national hepatitis B vaccination","volume":"25","author":"Su","year":"2007","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.05.046_bib0230","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2334-10-9","article-title":"Lasting immune memory against hepatitis B in children after primary immunization with 4 doses of DTPa\u2013HBV\u2013IPV\/Hib in the first and 2nd year of life","volume":"15","author":"Steiner","year":"2010","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.05.046_bib0235","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.vaccine.2009.10.074","article-title":"Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand","volume":"28","author":"Poovorawan","year":"2010","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2011.05.046_bib0240","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S1473-3099(10)70195-X","article-title":"Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study","volume":"10","author":"Zanetti","year":"2010","journal-title":"Lancet Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11007663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T07:54:44Z","timestamp":1686124484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11007663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":48,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0264410X11007663"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.05.046","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}